Publications by authors named "Mari Ohwashi"

Article Synopsis
  • The study focused on the role of PRAME (preferentially expressed antigen in melanoma) in bone marrow cells from 116 patients with myelodysplastic syndromes (MDS).
  • High levels of PRAME expression were linked to worse survival rates in MDS patients, particularly those with low bone marrow blast percentages and lower IPSS-R risk categories.
  • The findings indicate that PRAME could serve as a potential prognostic factor for assessing disease progression and outcomes in MDS patients.
View Article and Find Full Text PDF

Deletion of the long arm of chromosome 20 (del(20q)) is observed in 5-10% of patients with myelodysplastic syndromes (MDS). We examined the expression of 28 genes within the common deleted region (CDR) of del(20q), which we previously determined by a CGH array using clinical samples, in 48 MDS patients with (n = 28) or without (n = 20) chromosome 20 abnormalities and control subjects (n = 10). The expression level of 8 of 28 genes was significantly reduced in MDS patients with chromosome 20 abnormalities compared to that of control subjects.

View Article and Find Full Text PDF

L265P mutation in the MYD88 gene has recently been reported in Waldenström's macroglobulinemia; however the incidence has been different according to the methods used. To determine the relevance and compare the incidence by different methods, we analyzed the L265P mutation in bone marrow mononuclear cells from lymphoid neoplasms. We first performed cloning and sequencing in 10 patients: 8 Waldenström's macroglobulinemia; 1 non-IgM-secreting lymphoplasmacytic lymphoma; and 1 low grade B-cell lymphoma with monoclonal IgG protein.

View Article and Find Full Text PDF

We performed methylation specific PCR analysis on the RIZ1 promoter in MDS and AML. Methylation was detected in 17 of 34 MDS (50%) and 22 of 72 AML (31%) (p=0.053).

View Article and Find Full Text PDF